Genomics-based KGF-2 (repifermin) and its receptors function effectively in infected wounds

Journal of Applied Research

Volumn 3, Issue 2, 2003, Pages 97-103

  Robson, Martin C ^a,b   Wright, Terry E ^a,b   Ko, Francis ^a   Connolly, Kevin M ^c   Halpern, Wendy ^c   Payne, Wyatt G ^a,b  

^a Bay Pines VA Medical Center   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Bacteria; Growth factors; Matrix metalloproteinases; Receptors; Repifermin

Indexed keywords

FIBROBLAST GROWTH FACTOR 10; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; REPIFERMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; GENOMICS; GRANULATION TISSUE; GROWTH STIMULATION; MALE; NONHUMAN; RAT; WOUND INFECTION;

EID: 0141457723     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Robson MC, Phillips TJ, Falanga V, et al: Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Rep Regen 9:347-352, 2001.
2. Tagashira S, Harade H, Katsumata T, Itoh N, Nakatuka M: Cloning of mouse FGF 10 and up-regulation of its gene during wound healing. Gene 197:399-404, 1997.
3. Soler PM, Wright TE, Smith PD, et al: In vivo characterization of keratinocyte growth factor-2 as potential wound healing agent. Wound Rep Regen 7:172-178, 1999.
4. Igarashi M, Finch PW, Aaronson SA: Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J Biol Chem 273:13230-13235, 1998.
5. Jimenez PA, Greenwalt D, Mendrick DL, et al: Keratinocyte growth factor-2. In: Narula SK, Coffman R, Eds. New cytokines as potential drugs. Basel, Switzerland: Birhauser Verlag; 2000:101-119.
6. Duan DR, Jimenez PA, Gruber JR, et al: Identification of keratinocyte growth factor-2 that promotes cutaneous wound repair. Wound Rep Regen 5:A111, 1997.
7. Xia YP, Zhao Y, Marcus J, et al: Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischemia-impaired rabbit ear model and on scar formation. J Pathol 188:431-438, 1999.
8. Jimenez P, Telsika M, Liu B, Judis K, Rampy M, Antonaccia M: Keratinocyte growth factor-2: A wound healing agent with epidermal and dermal activity. Wound Rep Regen 5:A115, 1997.
9. Robson MC, Stenberg BD, Heggers JP: Wound healing alterations caused by infection. Clin Plast Surg 17:485-492, 1990.
10. Payne WG, Wright TE, Ko F, Wheeler C, Wang X, Robson MC: Bacterial degradation of growth factors. J Appl Res (in press).
11. Yager DR, Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Cohen IK: Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep Regen 5:23-32, 1997.
12. Hassan A, Murata H, Fallabella A, et al: Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor beta-1. J Dermatol Sci 16:59-66, 1997.
13. Hayward P, Hokanson J, Heggers J, et al: Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am J Surg 163:288-293, 1992.
14. Kuhn MA, Page L, Nguyen K, Wang X, Wachtel TL, Robson MC: Basic fibroblast growth factor in a carboxymethylcellulose vehicle reverses the bacterial retardation of wound contraction. Wounds 13:73-80, 2001.
15. Hayward PG, Robson MC: Animal models of wound contraction. In: Barbal A, Caldwell M, Eaglstein W, et al., Eds. Clinical and experimental approaches to dermal and epidermal repair: normal and chronic wounds. New York: Alan R. Liss; 1991:301-312.
16. Robson MC, Edstrom LE, Krizek TJ, Groskin MG: The efficacy of systemic antibiotics in the treatment of granulating wounds. J Surg Res 16:299-306, 1984.
17. Heggers JP: Variations on a theme. In: Heggers JP, Robson MC, Eds. Quantitative bacteriology: Its role in the armamentarium of the surgeon. Boca Raton, FL: CRC Press; 1991:15-23.
18. Hokanson JA, Hayward PG, Carney OH, Phillips LG, Robson MC: A mathematical model for the analysis of experimental wound healing data. Wounds 3:213-220, 1992.
19. Robson MC, Mustoe TA, Hunt TK: The future of recombinant growth factors in wound healing. Am J Surg 176(suppl):80s-82s, 1998.
20. Robson MC: Wound infection: A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 77:637-650, 1997.
21. Robson MC, Phillips LG, Thomason A, et al: Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg 29:193-201, 1992.
22. Robson MC, Phillips LG, Lawrence WT, et al: The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 216:401-408, 1992.
23. Kucukcelebei A, Carp SS, Hayward PG, et al: Granulocyte-macrophage colony stimulating factor reverses the inhibition of wound contraction caused by bacterial contamination. Wounds 4:241-247, 1992.
24. Emoto H, Tagashira S, Mahai M, et al: Structure and expression of human fibroblast growth factor-10. J Biol Chem 272:23191-23194, 1997.